Low homoarginine concentration is a novel risk factor for heart disease

Heart

Volumn 97, Issue 15, 2011, Pages 1222-1227

  Pilz, Stefan ^a,b   Meinitzer, Andreas ^a   Tomaschitz, Andreas ^a   Drechsler, Christiane ^c   Ritz, Eberhard ^d   Krane, Vera ^c   Wanner, Christoph ^c   Boehm, Bernhard O ^e   März, Winfried ^a,d,f  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF ULM   (Germany)

^f SYNLAB ACADEMY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GUANIDINOACETIC ACID; HOMOARGININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; FOLLOW UP; GERMANY; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY ANGIOGRAPHY; CREATININE; CROSS-SECTIONAL STUDIES; ENERGY METABOLISM; FEMALE; FOLLOW-UP STUDIES; GERMANY; GLYCINE; HEART DISEASES; HOMOARGININE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIUM; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS;

EID: 79960277834     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.220731     Document Type: Article

References (30)

1. Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 2010;121:1768-77.
2. Lewis GD, Asnani A, Gerszten RE. Application of metabolomics to cardiovascular biomarkers and pathway discovery. J Am Coll Cardiol 2008;52:117-23. (Pubitemid 351885452)
3. Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids 2009;37:1-17.
4. Ryan WL, Johnson RJ, Dimari S. Homoarginine synthesis by rat kidney. Arch Biochem Biophys 1969;131:521-6.
5. Valtonen P, Laitinen T, Lyyra-Laitinen T, et al. Serum L-homoarginine is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 2008;72:1879-84.
6. Henningsson R, Lundquist I. Arginine-induced insulin release is decreased and glucagon increased in parallel with islet NO production. Am J Physiol 1998;275:E500-6.
7. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A 1990;87:5193-7.
8. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 1993;22:812-18. (Pubitemid 23358087)
9. Kakoki M, Kim HS, Edgell CJ, et al. Amino acids as modulators of endothelium-derived nitric oxide. Am J Physiol Renal Physiol 2006;291:F297-304.
10. März W, Meinitzer A, Drechsler C, et al. Homoarginine, cardiovascular risk, and mortality. Circulation 2010;122:967-75.
11. Blachier F, Mourtada A, Sener A, et al. Stimulus-secretion coupling of arginine-induced insulin release. Uptake of metabolized and nonmetabolized cationic amino acids by pancreatic islets. Endocrinology 1989;124:134-41.
12. Cullen ME, Yuen AH, Felkin LE, et al. Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation 2006;114:16-20.
13. Item CB, Stöckler-Ipsiroglu S, Stromberger C, et al. Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet 2001;69:1127-33. (Pubitemid 33015826)
14. Winkelmann BR, Marz W, Boehm BO, et al. Rationale and design of the LURIC studyea resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001;2:S1-73.
15. Meinitzer A, Puchinger M, Winklhofer-Roob BM, et al. Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method. Clin Chim Acta 2007;384:141-8. (Pubitemid 47248653)
16. Meinitzer A, Kielstein JT, Pilz S, et al. Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 2011;57:112-21.
17. Young S, Struys E, Wood T. Quantification of creatine and guanidinoacetate using GC-MS and LC-MS/MS for the detection of cerebral creatine deficiency syndromes. Curr Protoc Hum Genet 2007;17:17.3.
18. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
19. The International Expert Committee. International expert committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.
20. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:e247-346.
21. Lagerqvist B, Diderholm E, Lindahl B, et al. FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Heart 2005;91:1047-52. (Pubitemid 41060013)
22. Pilz S, Tomaschitz A, Drechsler C, et al. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 2010;31:1591-8.
23. Da Silva RP, Nissim I, Brosnan ME, et al. Creatine synthesis: hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo. Am J Physiol Endocrinol Metab 2009;296:256-61.
24. McClure WC, Rabon R, Ogawa H, et al. Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice. Neuromuscul Disord 2007;17:639-50. (Pubitemid 47033926)
25. Katz LA, Swain JA, Protman MA, et al. Relation between phosphate metabolites and oxygen consumption of heart in vivo. Am J Physiol 1989;256:H265-74.
26. Hall JL, Birks EJ, Grindle S, et al. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 2007;28:613-27. (Pubitemid 47355497)
27. Köttgen A, Glazer NL, Dehghan A, et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009;41:712-17.
28. Chambers JC, Zhang W, Lord GM, et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 2010;42:373-5.
29. Bauersachs J, Widder JD. Endothelial dysfunction in heart failure. Pharmacol Rep 2008;60:119-26. (Pubitemid 351586550)
30. Ruiz-Hurtado G, Delgado C. Nitric oxide pathway in hypertrophied heart: new therapeutic uses of nitric oxide donors. J Hypertens 2010;28(Suppl 1):S56-61.